Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ARMP

Armata Pharmaceuticals Inc

Last Close
May 10 • 04:00PM ET
3.09
Dollar change
-0.17
Percentage change
-5.18 		%
Scroll to Statements
Index- P/E- EPS (ttm)-2.20 Insider Own70.35% Shs Outstand36.12M Perf Week24.14%
Market Cap111.75M Forward P/E- EPS next Y-1.21 Insider Trans0.00% Shs Float10.72M Perf Month-6.61%
Income-79.58M PEG- EPS next Q-0.37 Inst Own3.91% Short Float0.10% Perf Quarter-19.29%
Sales4.70M P/S23.78 EPS this Y17.28% Inst Trans0.57% Short Ratio0.66 Perf Half Y39.87%
Book/sh-1.56 P/B- EPS next Y23.73% ROA-69.46% Short Interest0.01M Perf Year128.98%
Cash/sh1.05 P/C2.95 EPS next 5Y- ROE-3439.35% 52W Range1.07 - 5.26 Perf YTD-4.59%
Dividend Est.- P/FCF- EPS past 5Y47.98% ROI-1100.03% 52W High-41.19% Beta0.86
Dividend TTM- Quick Ratio0.38 Sales past 5Y89.79% Gross Margin78.06% 52W Low188.87% ATR (14)0.36
Dividend Ex-Date- Current Ratio0.38 EPS Y/Y TTM-86.31% Oper. Margin-846.39% RSI (14)54.13 Volatility16.23% 12.96%
Employees66 Debt/Eq- Sales Y/Y TTM-7.28% Profit Margin-1693.47% Recom1.00 Target Price8.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-72.29% Payout- Rel Volume0.60 Prev Close3.26
Sales Surprise-12.18% EPS Surprise-122.58% Sales Q/Q21.36% EarningsMay 07 AMC Avg Volume16.20K Price3.09
SMA2014.18% SMA50-6.54% SMA2002.10% Trades Volume9,754 Change-5.18%
Date Action Analyst Rating Change Price Target Change
Jun-19-19Initiated Ladenburg Thalmann Buy $9
May-07-24 04:01PM
Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update
(PR Newswire) +13.94%
Mar-21-24 04:05PM
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update
(PR Newswire)
Mar-04-24 04:01PM
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva
(PR Newswire)
Feb-21-24 07:00AM
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit
(PR Newswire)
Nov-14-23 04:00PM
Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
(PR Newswire) +8.94%
08:00AM Loading…
Oct-30-23 08:00AM
Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference
(PR Newswire) +10.19%
Oct-19-23 08:00AM
Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023
(PR Newswire)
Sep-26-23 08:00AM
Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
(PR Newswire)
Sep-21-23 07:00AM
Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference
(PR Newswire)
Aug-17-23 09:55AM
Armata Pharmaceuticals, Inc. (ARMP) Now Trades Above Golden Cross: Time to Buy?
(Zacks)
Aug-14-23 07:00AM
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update
(PR Newswire)
Jul-11-23 08:00AM
Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics
(PR Newswire)
May-31-23 08:00AM
Armata Pharmaceuticals Announces Oral Presentation Detailing Results from the Phase 1b/2a SWARM-P.a. Clinical Trial at the 6th World Conference on Targeting Phage Therapy
(PR Newswire)
May-11-23 04:05PM
Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update
(PR Newswire)
Mar-16-23 04:10PM
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Update
(PR Newswire) +5.42%
06:00AM Loading…
Mar-06-23 06:00AM
Armata Pharmaceuticals Announces Positive Topline Data from Phase 1b/2a SWARM-P.a. Clinical Trial of Inhaled AP-PA02 in Patients with Cystic Fibrosis
(PR Newswire) +10.87%
Jan-10-23 04:05PM
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC
(PR Newswire) +25.38%
Dec-22-22 08:00AM
Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection
(PR Newswire) -6.99%
Dec-08-22 09:55AM
Armata Pharmaceuticals, Inc. (ARMP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
(Zacks)
Nov-28-22 09:35AM
After Plunging 35.3% in 4 Weeks, Here's Why the Trend Might Reverse for Armata Pharmaceuticals, Inc. (ARMP)
(Zacks)
08:00AM
Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage
(PR Newswire)
Nov-15-22 09:55AM
Here's Why Armata Pharmaceuticals, Inc. (ARMP) Looks Ripe for Bottom Fishing
(Zacks) -9.66%
Nov-09-22 04:15PM
Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update
(PR Newswire)
Aug-11-22 04:05PM
Armata Pharmaceuticals Announces Second Quarter 2022 Results and Provides Corporate Update
(PR Newswire)
Aug-01-22 08:00AM
Armata Pharmaceuticals Announces Clearance of IND for Prosthetic Joint Infections
(PR Newswire)
May-23-22 08:00AM
Armata Pharmaceuticals Announces First Patient Dosed in Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia due to Staphylococcus aureus
(PR Newswire)
May-12-22 04:17PM
Armata Pharmaceuticals Announces First Quarter 2022 Results and Provides Corporate Update
(PR Newswire) -5.00%
Mar-31-22 04:05PM
Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $45 Million Private Placement with Innoviva
(PR Newswire) -8.60%
Mar-22-22 10:00AM
Wall Street Analysts See a 52% Upside in Armata Pharmaceuticals, Inc. (ARMP): Can the Stock Really Move This High?
(Zacks) +5.17%
Mar-17-22 04:05PM
Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
(PR Newswire) +5.37%
05:28PM Loading…
Mar-09-22 05:28PM
Armata Pharmaceuticals to move headquarters to Playa Vista
(American City Business Journals)
Feb-22-22 08:00AM
Armata Pharmaceuticals Announces Clearance of Investigational New Drug Application to Initiate Phase 2 Clinical Trial of AP-PA02 in Non-Cystic Fibrosis Bronchiectasis
(PR Newswire)
Feb-17-22 08:00AM
Armata Pharmaceuticals to Participate in Two Upcoming Investor Conferences
(PR Newswire)
Feb-09-22 04:16PM
Armata Pharmaceuticals Announces $45 Million Investment to Support Advancement of the Company's Bacteriophage Development
(PR Newswire)
Jan-06-22 08:50AM
Recent Price Trend in Armata Pharmaceuticals, Inc. (ARMP) is Your Friend, Here's Why
(Zacks) +7.12%
Jan-05-22 08:00AM
Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs
(PR Newswire) +6.12%
Nov-29-21 10:00AM
Wall Street Analysts Believe Armata Pharmaceuticals, Inc. (ARMP) Could Rally 47%: Here's is How to Trade
(Zacks) -17.62%
Nov-18-21 08:00AM
Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs
(PR Newswire)
Nov-17-21 12:00PM
What Makes Armata Pharmaceuticals, Inc. (ARMP) a New Buy Stock
(Zacks) +8.07%
Nov-10-21 04:05PM
Armata Pharmaceuticals Announces Third Quarter Results and Provides General Corporate Update
(PR Newswire)
Nov-04-21 03:01PM
Armata Pharmaceuticals, Inc. (ARMP) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
(Zacks)
08:00AM
Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress
(PR Newswire)
Nov-02-21 08:00AM
Armata Enters Lease to Build State-of-the-Art R&D and GMP Manufacturing Facility
(PR Newswire)
Oct-28-21 06:41PM
Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals
(PR Newswire)
Sep-08-21 08:00AM
Armata Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
(PR Newswire)
Aug-12-21 04:05PM
Armata Pharmaceuticals Announces Second Quarter Results and Provides General Corporate Update
(PR Newswire)
Aug-05-21 03:00PM
Will Armata Pharmaceuticals, Inc. (ARMP) Report Negative Q2 Earnings? What You Should Know
(Zacks)
Aug-02-21 07:30AM
Armata Pharmaceuticals Announces Chief Executive Officer Transition
(PR Newswire)
Jul-07-21 07:30AM
Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
(PR Newswire)
May-13-21 04:05PM
Armata Pharmaceuticals Announces First Quarter Results and Provides General Corporate Update
(PR Newswire)
10:45AM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Armata Pharmaceuticals Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
(PR Newswire)
Mar-18-21 04:05PM
Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and Provides General Corporate Update
(PR Newswire)
Mar-17-21 04:01PM
Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $20 Million Private Placement with Innoviva
(PR Newswire)
Mar-16-21 11:01AM
Armata Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference
(PR Newswire)
Jan-27-21 07:01AM
Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs
(PR Newswire)
Dec-09-20 07:30AM
Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board of Directors
(PR Newswire)
Nov-16-20 11:10PM
Brokers Are Upgrading Their Views On Armata Pharmaceuticals Inc. (NYSEMKT:ARMP) With These New Forecasts
(Simply Wall St.) -13.97%
Nov-15-20 07:17AM
Earnings Beat: Armata Pharmaceuticals Inc. (NYSEMKT:ARMP) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
(Simply Wall St.)
Nov-12-20 04:05PM
Armata Pharmaceuticals Announces Third Quarter 2020 Results and Provides General Corporate Update
(PR Newswire) +7.95%
Oct-29-20 07:30AM
Armata Pharmaceuticals Issues Letter to Shareholders
(PR Newswire) +7.00%
Oct-26-20 07:30AM
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
(PR Newswire)
Oct-15-20 07:30AM
Armata Pharmaceuticals Announces Clearance of Investigational New Drug (IND) Application to Initiate Phase 1b/2a Clinical Trial of Lead Candidate AP-PA02 in Pseudomonas aeruginosa Infections
(PR Newswire) +8.86%
Sep-29-20 07:30AM
Armata Pharmaceuticals to Present at the Virtual 2020 World Antimicrobial Resistance Congress
(PR Newswire)
Sep-11-20 07:30AM
Armata Pharmaceuticals Announces Participation in Upcoming Investor Conferences
(PR Newswire)
Aug-13-20 04:05PM
Armata Pharmaceuticals Announces Second Quarter 2020 Results and Provides General Corporate Update
(PR Newswire)
Jun-30-20 06:05AM
Here's Why We're Watching Armata Pharmaceuticals's (NYSEMKT:ARMP) Cash Burn Situation
(Simply Wall St.)
Jun-17-20 07:30AM
Armata Pharmaceuticals Announces $15 Million Award from the U.S. Department of Defense (DoD) for Development of Bacteriophage Therapy to Treat S. aureus Bacteremia Infections
(PR Newswire) +10.33%
May-14-20 04:05PM
Armata Pharmaceuticals Announces First Quarter 2020 Results and Provides General Corporate Update
(PR Newswire)
Apr-28-20 08:00AM
Armata Pharmaceuticals to Participate in the Maxim Group M-Vest Infectious Disease Virtual Conference: The Renaissance of the Anti-Infective Sector
(PR Newswire)
Mar-30-20 07:30AM
Armata Pharmaceuticals Announces Closing of Second Tranche of $25 Million Securities Purchase Agreement with Innoviva, Inc.
(PR Newswire)
Mar-19-20 04:05PM
Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Results and Provides General Corporate Update
(PR Newswire) -6.46%
Mar-18-20 08:00AM
Armata Pharmaceuticals Announces up to $5 Million Therapeutics Development Award from the Cystic Fibrosis Foundation
(PR Newswire) +10.94%
Feb-13-20 08:00AM
Armata Pharmaceuticals Announces Closing of First Tranche of Recently Executed $25 Million Securities Purchase Agreement with Innoviva, Inc.
(PR Newswire)
Jan-29-20 08:04AM
Company News For Jan 29, 2020
(Zacks) -26.80%
Jan-28-20 07:00AM
Armata Pharmaceuticals and Innoviva Announce $25 Million Strategic Investment to Support Advancement of Armata's Bacteriophage Development Programs
(PR Newswire) +73.84%
Nov-12-19 04:05PM
Armata Pharmaceuticals Announces Third Quarter Results and Provides Corporate and Clinical Update
(PR Newswire)
Oct-31-19 10:52AM
We're Keeping An Eye On Armata Pharmaceuticals's (NYSEMKT:ARMP) Cash Burn Rate
(Simply Wall St.)
07:05AM
Armata Pharmaceuticals Issues Letter to Shareholders
(PR Newswire)
Oct-21-19 07:05AM
Armata Pharmaceuticals Announces Receipt of $1.3 million R&D Tax Incentive
(PR Newswire)
Oct-16-19 07:05AM
Armata Pharmaceuticals Strengthens Clinical Team with Appointment of Dr. Heather Dale Jones as Medical Director
(PR Newswire)
Oct-10-19 04:05PM
Armata Pharmaceuticals Expands Board of Directors with the Appointment of Research and Development Veteran Todd C. Peterson, Ph.D.
(PR Newswire)
Sep-19-19 07:05AM
Armata Pharmaceuticals to Participate in the Ladenburg Thalmann 2019 Healthcare Conference
(PR Newswire)
Sep-12-19 09:00AM
Armata Pharmaceuticals Announces Development of New Synthetic Phage Candidate Targeting Pseudomonas aeruginosa
(PR Newswire)
Aug-14-19 04:05PM
Armata Pharmaceuticals Announces Second Quarter Results and Provides Corporate and Clinical Update
(PR Newswire)
Aug-02-19 03:27PM
How Much Of Armata Pharmaceuticals, Inc. (NYSEMKT:ARMP) Do Institutions Own?
(Simply Wall St.)
Aug-01-19 10:30AM
Armata Pharmaceuticals to Provide Corporate Update at the 39th Annual Canaccord Genuity Growth Conference
(PR Newswire)
Jun-18-19 07:01AM
Armata Pharmaceuticals to Host Key Opinion Leader Meeting on Bacteriophage-Based Therapeutics on June 26 in New York
(PR Newswire)
Jun-03-19 07:01AM
Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with New Patent Allowances in Europe and Canada
(PR Newswire) -5.96%
May-28-19 07:01AM
Armata Pharmaceuticals Announces Publication of Successful Adjunctive Phage Treatment in Cystic Fibrosis Patient
(PR Newswire) +31.67%
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.